Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.170

-0.085 (-3.77%)

At close: Feb 21, 2025, 4:00 PM

2.169

-0.001 (-0.04%)

After-hours: Feb 21, 2025, 7:45 PM EST

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $454.99 million as of February 21, 2025. Its market cap has decreased by -34.21% in one year.

Market Cap

454.99M

Enterprise Value

255.95M

1-Year Change

-34.21%

Ranking

#3043

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $454.99M, a decrease of -84.21%. That is a compound annual growth rate of -25.15%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	454.99M	1.88%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings